BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26461109)

  • 1. Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Rouprêt M
    Eur Urol; 2016 Mar; 69(3):e51-2. PubMed ID: 26461109
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Shibing Y; Qiang W
    Eur Urol; 2016 Mar; 69(3):e49-50. PubMed ID: 26461110
    [No Abstract]   [Full Text] [Related]  

  • 3. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Tim O'Brien, Eleanor Ray, Rajinder Singh, Bola Coker, Ralph Beard, British Association of Urological Surgeons Section of Oncology. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 2011;60:703-10.
    Goel A; Paul S
    Eur Urol; 2012 Mar; 61(3):e14; author reply e15. PubMed ID: 22189381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the upper urinary tract].
    Gustin P; Yossi S; Lafont M; Peyraga G; Trémolières P; Rousseau D; Cellier P; Paumier A; Martin F; Chapet O; Mesgouez-Nebout N
    Cancer Radiother; 2015 Apr; 19(2):120-6. PubMed ID: 25770883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
    O'Brien T; Ray E; Singh R; Coker B; Beard R;
    Eur Urol; 2011 Oct; 60(4):703-10. PubMed ID: 21684068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience.
    Motamedinia P; Keheila M; Leavitt DA; Rastinehad AR; Okeke Z; Smith AD
    J Endourol; 2016 Mar; 30(3):262-7. PubMed ID: 26630130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organ preservation in cancer of the upper urinary tract].
    Vom Dorp F
    Urologe A; 2019 Jan; 58(1):22-24. PubMed ID: 30649581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
    J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
    Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
    World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052-68: The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.
    Seisen T; Babjuk M; Rouprêt M
    Eur Urol; 2017 Apr; 71(4):e111-e112. PubMed ID: 27666997
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61.
    Babjuk M; Burger M; Compérat E; Palou J; Rouprêt M; van Rhijn B; Shariat S; Sylvester R; Zigeuner R; Gontero P; Mostafid H
    Eur Urol; 2017 Jun; 71(6):e173-e174. PubMed ID: 27939074
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14.
    Orsola A; Cecchini L; Morote J
    Eur Urol; 2009 Jan; 55(1):e15-6; author reply e17-8. PubMed ID: 18692301
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Nieder AM
    J Urol; 2010 Jan; 183(1):61. PubMed ID: 19913834
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Ching-Chia Li, Tu-Hao Chang, Wen-Jeng Wu, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in taiwanese patients. Eur Urol 2008;54:1127-35.
    Chung SD; Yu HJ; Chueh SC
    Eur Urol; 2009 Apr; 55(4):e69-70; author reply e71. PubMed ID: 18367314
    [No Abstract]   [Full Text] [Related]  

  • 17. Conservative nephron-sparing treatment of upper-tract tumors.
    Smith P; Mandel J; Raman JD
    Curr Urol Rep; 2013 Apr; 14(2):102-8. PubMed ID: 23344683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61.
    Mouracade P
    J Urol; 2010 Oct; 184(4):1571. PubMed ID: 20728904
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: The Effect of Intravesical Chemotherapy in the Prevention of Intravesical Recurrence after Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Meta-Analysis.
    Chang SS
    J Urol; 2016 Nov; 196(5):1400-1401. PubMed ID: 27751450
    [No Abstract]   [Full Text] [Related]  

  • 20. Postoperative intravesical therapy to prevent bladder tumor recurrence: are we ready to listen yet?
    Boorjian SA
    Eur Urol; 2011 Oct; 60(4):711-2. PubMed ID: 21715085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.